269 related articles for article (PubMed ID: 19379710)
1. Molecular mechanisms controlling E-cadherin expression in breast cancer.
Baranwal S; Alahari SK
Biochem Biophys Res Commun; 2009 Jun; 384(1):6-11. PubMed ID: 19379710
[TBL] [Abstract][Full Text] [Related]
2. A Ca
Dang DK; Makena MR; Llongueras JP; Prasad H; Ko M; Bandral M; Rao R
Mol Cancer Res; 2019 Aug; 17(8):1735-1747. PubMed ID: 31076498
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of E- and P-cadherin in invasive breast cancer cells.
Sarrió D; Palacios J; Hergueta-Redondo M; Gómez-López G; Cano A; Moreno-Bueno G
BMC Cancer; 2009 Mar; 9():74. PubMed ID: 19257890
[TBL] [Abstract][Full Text] [Related]
4. Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells.
Vergara D; Simeone P; Latorre D; Cascione F; Leporatti S; Trerotola M; Giudetti AM; Capobianco L; Lunetti P; Rizzello A; Rinaldi R; Alberti S; Maffia M
J Biotechnol; 2015 May; 202():3-11. PubMed ID: 25449012
[TBL] [Abstract][Full Text] [Related]
5. PKCζ Promotes Breast Cancer Invasion by Regulating Expression of E-cadherin and Zonula Occludens-1 (ZO-1) via NFκB-p65.
Paul A; Danley M; Saha B; Tawfik O; Paul S
Sci Rep; 2015 Jul; 5():12520. PubMed ID: 26218882
[TBL] [Abstract][Full Text] [Related]
6. ERalpha as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells.
Cardamone MD; Bardella C; Gutierrez A; Di Croce L; Rosenfeld MG; Di Renzo MF; De Bortoli M
Proc Natl Acad Sci U S A; 2009 May; 106(18):7420-5. PubMed ID: 19383788
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.
Tryndyak VP; Beland FA; Pogribny IP
Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049
[TBL] [Abstract][Full Text] [Related]
8. The Influence of VE-Cadherin on Adhesion and Incorporation of Breast Cancer Cells into Vascular Endothelium.
Brock T; Boudriot E; Klawitter A; Großer M; Nguyen TTP; Giebe S; Klapproth E; Temme A; El-Armouche A; Breier G
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205118
[TBL] [Abstract][Full Text] [Related]
9. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24.
Teo WW; Merino VF; Cho S; Korangath P; Liang X; Wu RC; Neumann NM; Ewald AJ; Sukumar S
Oncogene; 2016 Oct; 35(42):5539-5551. PubMed ID: 27157614
[TBL] [Abstract][Full Text] [Related]
10. Increased α-actinin-1 destabilizes E-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer.
Kovac B; Mäkelä TP; Vallenius T
PLoS One; 2018; 13(5):e0196986. PubMed ID: 29742177
[TBL] [Abstract][Full Text] [Related]
11. Alterations of E-cadherin and beta-catenin in gastric cancer.
Huiping C; Kristjansdottir S; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S
BMC Cancer; 2001; 1():16. PubMed ID: 11747475
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
Shah P; Gau Y; Sabnis G
Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion.
Kelly NJ; Varga JFA; Specker EJ; Romeo CM; Coomber BL; Uniacke J
Oncogene; 2018 Feb; 37(5):651-662. PubMed ID: 28991229
[TBL] [Abstract][Full Text] [Related]
14. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
[TBL] [Abstract][Full Text] [Related]
15. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
16. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
Hollestelle A; Peeters JK; Smid M; Timmermans M; Verhoog LC; Westenend PJ; Heine AA; Chan A; Sieuwerts AM; Wiemer EA; Klijn JG; van der Spek PJ; Foekens JA; Schutte M; den Bakker MA; Martens JW
Breast Cancer Res Treat; 2013 Feb; 138(1):47-57. PubMed ID: 23338761
[TBL] [Abstract][Full Text] [Related]
17. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
Arima Y; Inoue Y; Shibata T; Hayashi H; Nagano O; Saya H; Taya Y
Cancer Res; 2008 Jul; 68(13):5104-12. PubMed ID: 18593909
[TBL] [Abstract][Full Text] [Related]
18. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.
He Y; Northey JJ; Pelletier A; Kos Z; Meunier L; Haibe-Kains B; Mes-Masson AM; Côté JF; Siegel PM; Lamarche-Vane N
Oncogene; 2017 Jun; 36(24):3490-3503. PubMed ID: 28135249
[TBL] [Abstract][Full Text] [Related]
19. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps.
Na TY; Schecterson L; Mendonsa AM; Gumbiner BM
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5931-5937. PubMed ID: 32127478
[TBL] [Abstract][Full Text] [Related]
20. The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer.
Fei F; Zhang D; Yang Z; Wang S; Wang X; Wu Z; Wu Q; Zhang S
J Exp Clin Cancer Res; 2015 Dec; 34():158. PubMed ID: 26702618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
